These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 22450811)
1. Resolvin E2 formation and impact in inflammation resolution. Oh SF; Dona M; Fredman G; Krishnamoorthy S; Irimia D; Serhan CN J Immunol; 2012 May; 188(9):4527-34. PubMed ID: 22450811 [TBL] [Abstract][Full Text] [Related]
2. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Tjonahen E; Oh SF; Siegelman J; Elangovan S; Percarpio KB; Hong S; Arita M; Serhan CN Chem Biol; 2006 Nov; 13(11):1193-202. PubMed ID: 17114001 [TBL] [Abstract][Full Text] [Related]
3. Resolvin E1 metabolome in local inactivation during inflammation-resolution. Hong S; Porter TF; Lu Y; Oh SF; Pillai PS; Serhan CN J Immunol; 2008 Mar; 180(5):3512-9. PubMed ID: 18292578 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. Freire MO; Dalli J; Serhan CN; Van Dyke TE J Immunol; 2017 Jan; 198(2):718-728. PubMed ID: 27994073 [TBL] [Abstract][Full Text] [Related]
5. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease. Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973 [TBL] [Abstract][Full Text] [Related]
6. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages. Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755 [TBL] [Abstract][Full Text] [Related]
7. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Herrera BS; Hasturk H; Kantarci A; Freire MO; Nguyen O; Kansal S; Van Dyke TE Infect Immun; 2015 Feb; 83(2):792-801. PubMed ID: 25486994 [TBL] [Abstract][Full Text] [Related]
8. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Arita M; Ohira T; Sun YP; Elangovan S; Chiang N; Serhan CN J Immunol; 2007 Mar; 178(6):3912-7. PubMed ID: 17339491 [TBL] [Abstract][Full Text] [Related]
9. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Hasturk H; Kantarci A; Goguet-Surmenian E; Blackwood A; Andry C; Serhan CN; Van Dyke TE J Immunol; 2007 Nov; 179(10):7021-9. PubMed ID: 17982093 [TBL] [Abstract][Full Text] [Related]
10. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. El Kebir D; Gjorstrup P; Filep JG Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14983-8. PubMed ID: 22927428 [TBL] [Abstract][Full Text] [Related]
19. The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Gyurko R; Van Dyke TE Crit Rev Immunol; 2014; 34(4):347-57. PubMed ID: 24941160 [TBL] [Abstract][Full Text] [Related]
20. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]